Skip to Main Content

Paper Details

Clonal Hematopoiesis of Indeterminate Potential Predicts Adverse Outcomes in Patients With Atherosclerotic Cardiovascular Disease.
7
2023
ASCVD, ASXL1, Atherosclerotic Cardiovascular Disease, CHIP, CHIP clones, Clonal hematopoiesis of indeterminate, DNA damage repair genes, DNMT3A, JAK2, PPM1D, Patients, SF3B1, SRSF2, TET2, TP53, U2AF1, all, atherosclerotic cardiovascular disease, blood stem cells, driver genes, leukemia, spliceosome genes, whole-exome sequences
Author NameAffiliation
Tetsushi NakaoBroad Institute of Harvard and Massachusetts Institute of Technology, USA Cardiovascular Research Center and Center for Genomic Medicine, Massachusetts General Hospital, Dana-Farber Cancer Institute, Brigham and Women's Hospital
Abhishek NiroulaBroad Institute of Harvard and Massachusetts Institute of Technology, Dana-Farber Cancer Institute, Lund University
Siddhartha JaiswalStanford University School of Medicine
Peter LibbyBrigham and Women's Hospital
Benjamin L EbertDana-Farber Cancer Institute
Pradeep NatarajanMassachusetts General Hospital, Broad Institute of Harvard and Massachusetts Institute of Technology, USA Cardiovascular Research Center and Center for Genomic Medicine
  • 1 - 6

Datasets

Release 1.2